Načítá se...
Evaluation of Quality of Life at Progression in Patients with Soft Tissue Sarcoma
Introduction. Soft Tissue Sarcoma (STS) is a rare malignancy of mesodermal tissue, with international incidence estimates between 1.8 and 5 per 100,000 per year. Understanding quality of life (QoL) and the detrimental impact of disease progression is critical for long-term care and survival. Objecti...
Uloženo v:
| Vydáno v: | Sarcoma |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Hindawi
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5420413/ https://ncbi.nlm.nih.gov/pubmed/28512389 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/2372135 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|